| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.00092 | 1 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.00096 | 1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.00074 | 1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.001 | 1 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.00078 | 1 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.00033 | 1 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.00025 | 1 |